Complications of Totally Implantable Central Venous Catheters (Ports) Inserted via the Internal Jugular Vein Under Ultrasound and Fluoroscopy Guidance in Adult Oncology Patients: A Single-Center Experience.

chemotherapy cytotoxic drugs drug administration iv therapy parenteral nutrition

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jul 2022
Historique:
accepted: 30 07 2022
entrez: 5 9 2022
pubmed: 6 9 2022
medline: 6 9 2022
Statut: epublish

Résumé

Introduction In this retrospective study, the safety and complication rates of port implantations via the internal jugular vein under ultrasound and fluoroscopy guidance in adult oncology patients were analyzed. Material and methods Eight hundred seven ports implanted in 799 adult oncology patients at a tertiary Oncology-Anticancer Hospital during a 36-month period from January 1, 2017 to December 31, 2019 were retrospectively reviewed. Data acquisition was obtained until December 31, 2020. All procedures were performed by two specialized interventional radiologists under ultrasound and fluoroscopy guidance. The vein access was via the internal jugular vein. Catheter days (the total number of days of maintenance of the port by all of the patients until removal, death, or December 31, 2020), technical success rates, and complication rates were evaluated based on the interventional radiological reports and patient medical records. Multivariate analysis regarding patients such as age, sex, body mass index (BMI), marital status, educational level, cancer type, side of insertion, diameter of internal jugular vein, diabetes, anticoagulants/antiplatelets, purpose of implantation, and catheter material as to the risk of complications was conducted. Results A total of 369,329 catheter maintenance days were observed (457.7±345.0). The technical success rate was 99.9%, and a total of 85 (10.5%) complications occurred, of which 24 (28.2%) occurred early (<30 days) and the remaining 61 (71.8%) were late (>30 days) complications. Specifically, 28 (3.5%) were catheter-related thrombosis (CRT), 27 (3.4%) related to infection, 17 (2.1%) were mechanical complications (16 fibrin sheath formation and one catheter occlusion), six (0.7%) related to catheter migration, four (0.5%) related to incision healing problems, and the remaining three (0.4%) related to ischemic skin necrosis. Forty-seven (5.8%) ports were removed due to complications. On multivariate analysis, cancer type was found as a risk factor for the development of a complication. Additionally, there was an indication that hematologic malignancy is related to infection. Conclusion Placement of ports via the internal jugular vein under ultrasound and fluoroscopy guidance is a safe procedure, with low rates of early and late complications.

Identifiants

pubmed: 36060391
doi: 10.7759/cureus.27485
pmc: PMC9421351
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e27485

Informations de copyright

Copyright © 2022, Kartsouni et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Thromb Haemost. 2011 Feb;9(2):312-9
pubmed: 21040443
Cancer. 1997 Apr 15;79(8):1635-40
pubmed: 9118051
Ann Oncol. 2009 May;20(5):935-40
pubmed: 19179550
Medicine (Baltimore). 2018 Sep;97(38):e12427
pubmed: 30235721
Korean J Radiol. 2012 May-Jun;13(3):314-23
pubmed: 22563269
World J Surg Oncol. 2014 Jan 14;12:15
pubmed: 24423026
Aust N Z J Med. 1996 Feb;26(1):33-9
pubmed: 8775526
Rofo. 2014 May;186(5):496-500
pubmed: 24756387
World J Gastroenterol. 2009 Oct 7;15(37):4709-14
pubmed: 19787834
Am J Infect Control. 2011 Sep;39(7):e39-43
pubmed: 21652113
Surgery. 2017 Aug;162(2):437-444
pubmed: 28535970
J Vasc Interv Radiol. 2017 Aug;28(8):1177-1183
pubmed: 28549710
Thromb Haemost. 2008 Jan;99(1):38-43
pubmed: 18217132
J Vasc Access. 2012 Jul-Sep;13(3):345-50
pubmed: 22307469
Support Care Cancer. 2014 Jun;22(6):1705-14
pubmed: 24659216
Radiology. 2001 Sep;220(3):655-60
pubmed: 11526263
Korean J Radiol. 2014 Jul-Aug;15(4):494-500
pubmed: 25053910
Eur Radiol. 2011 Jun;21(6):1224-32
pubmed: 21207035
Am J Infect Control. 2003 Feb;31(1):34-9
pubmed: 12548255
Br J Cancer. 2006 Jan 30;94(2):189-94
pubmed: 16404436
Support Care Cancer. 2020 Jun;28(6):2761-2768
pubmed: 31724073
Oncology. 2008;74(3-4):237-44
pubmed: 18716418
J Vasc Access. 2018 May;19(3):230-242
pubmed: 29512430
Eur J Surg Oncol. 2008 Dec;34(12):1340-3
pubmed: 18191364
J Vasc Access. 2004 Oct-Dec;5(4):174-8
pubmed: 16596562
Ann Oncol. 2008 Jan;19(1):9-15
pubmed: 17846025
J Am Coll Cardiol. 2000 Jun;35(7):1915-8
pubmed: 10841243
CA Cancer J Clin. 2008 Nov-Dec;58(6):323-46
pubmed: 18971486
J Formos Med Assoc. 2015 Nov;114(11):1055-60
pubmed: 26253646
J Vasc Access. 2016 Mar-Apr;17(2):155-61
pubmed: 26694207
J Vasc Interv Radiol. 2002 Oct;13(10):1009-16
pubmed: 12397122
Exp Ther Med. 2019 Mar;17(3):2013-2018
pubmed: 30867691
Int J Lab Hematol. 2007 Aug;29(4):261-78
pubmed: 17617077
AJR Am J Roentgenol. 1997 Nov;169(5):1431-4
pubmed: 9353475
Eur J Cancer. 2016 May;59:113-124
pubmed: 27023050
Tomography. 2022 Apr 03;8(2):1033-1040
pubmed: 35448717
Diagn Interv Radiol. 2006 Jun;12(2):93-8
pubmed: 16752357
Eur J Radiol. 2009 Mar;69(3):517-22
pubmed: 19340958
Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):133-8
pubmed: 22930406
J Clin Oncol. 2003 Oct 1;21(19):3665-75
pubmed: 14512399
Cardiovasc Intervent Radiol. 2012 Aug;35(4):751-64
pubmed: 21922348
Support Care Cancer. 2011 Jul;19(7):883-98
pubmed: 21556721
Am Surg. 1997 Apr;63(4):322-6
pubmed: 9124750
Support Care Cancer. 2018 Jan;26(1):81-89
pubmed: 28756472
Ann Intern Med. 2015 Sep 15;163(6 Suppl):S1-40
pubmed: 26369828
Crit Care Med. 1996 Dec;24(12):2053-8
pubmed: 8968276
Med Mal Infect. 2016 Feb;46(1):32-8
pubmed: 26778362
Surgery. 1982 Oct;92(4):706-12
pubmed: 7123491
J Vasc Interv Radiol. 2003 Sep;14(9 Pt 2):S443-52
pubmed: 14514860
BMC Cancer. 2016 Sep 22;16(1):747
pubmed: 27658952

Auteurs

Viktoria Kartsouni (V)

Interventional Unit of Radiology, Saint Savvas Hospital, Athens, GRC.

Hippocrates Moschouris (H)

Interventional Unit of Radiology, General Hospital of Piraeus "Tzaneio", Athens, GRC.

Fragiskos Bersimis (F)

Department of Midwifery, University of West Attica, Athens, GRC.

George Gkeneralis (G)

Interventional Unit of Radiology, Saint Savvas Hospital, Athens, GRC.

Myrsini Gkeli (M)

Interventional Unit of Radiology, Saint Savvas Hospital, Athens, GRC.

Stamatia Dodoura (S)

Interventional Unit of Radiology, Saint Savvas Hospital, Athens, GRC.

Aikaterini Chouchourelou (A)

Department of Radiology, University of Thessaly, Larissa, GRC.

Ioannis Fezoulidis (I)

Department of Radiology, University of Thessaly, Larissa, GRC.

Athanasios Kotsakis (A)

Department of Oncology, University of Thessaly, Larissa, GRC.

Christos Rountas (C)

Department of Radiology, University of Thessaly, Larissa, GRC.

Classifications MeSH